rfhg_240062.1

Basic information about the TSS

---

TSS ID: rfhg_240062.1 TSS ID(Version3): hg_197996.1 hg_197995.1 Species: human Chr: chrX		Start: 151397182 End: 151397298 Strand: +
Source datasets	FANTOM5|PRJNA597322|PRJNA4843412|DRA013844|PRJNA548673 |PRJNA615891|PRJNA401781|PRJDB5282
Protocol	CAGE|STRIPE-seq|NETCAGE|ReCappable-seq|TIF-seq2 |oligo_capping|SLIC_CAGE|RAMPAGE|C1CAGE
TSS cluster detected*	12

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D4320713,EH38E2773175)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000330374.7:0 AK096835:0 BC103701:0 BC103702:0 BC105693:0 BC105694:0 AL833596:0 BC110800:0 GeneID: 203547 HGNC/MGI_ID: HGNC:22082 UniProt_ID: Q3ZAQ7 Nearer transcript ids and distances: AM392666:7 KJ895820:7 AB528749:9 view more...

Gene_name: vacuolar ATPase assembly factor VMA21 Gene_symbol: VMA21 Gene_synonyms: XMEA Gene_source: HGNC:22082

TATA-Box annotation

---

Distance to TSS:	55
Nearest PromoterID:	NM_001017980
Entrez ID:	203547
Nearest Unigene:	Hs.58633
Nearest Refseq:	NM_001017980
Nearest Ensembl:	ENSG00000160131
Gene Name:	vacuolar ATPase assembly factor VMA21
Gene Alias:	MEAX|XMEA
Gene Type:	protein-coding
CpG%:	0.181034
GC%:	0.752137
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@VMA21 p2@VMA21 p3@VMA21
Sample		p1@VMA21	p2@VMA21	p3@VMA21
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	62.73	64.48	0.78
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	59.68	60.29	0.81
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	59.41	62.89	0.96
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	59.46	72.14	0.83
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	62.32	65.24	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	55.82	57.56	0.58
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	73.43	73.21	1.09
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	59.83	79.45	1.70
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	78.22	75.23	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	37.68	52.17	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	38.40	50.13	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	42.69	55.29	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	51.58	37.40	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	43.15	25.71	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	57.08	31.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	44.01	29.93	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	45.43	31.23	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	42.18	26.15	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	29.32	33.06	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	48.74	32.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	43.44	29.67	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	35.56	26.76	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	39.42	26.11	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	47.08	28.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	55.98	35.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	54.12	27.22	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	43.41	35.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	53.28	38.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	40.22	25.20	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	50.31	35.65	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	47.10	31.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	55.88	36.34	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	46.85	30.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	35.63	23.42	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	52.92	31.04	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	54.04	32.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	53.34	31.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	45.54	28.01	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	47.00	33.49	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	54.25	26.41	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	43.52	26.11	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	41.72	26.94	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	61.58	41.34	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	57.87	32.17	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	62.64	35.14	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	57.46	34.20	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	59.26	34.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	65.57	37.26	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	65.83	33.99	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	62.88	29.72	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	71.12	36.07	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	73.16	38.25	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	55.97	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	76.29	47.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	60.31	37.45	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	33.56	22.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	39.49	19.29	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	82.32	38.57	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	76.76	39.83	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	46.84	38.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	64.86	52.88	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	75.15	38.13	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	36.62	23.88	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	40.43	27.86	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	66.93	38.67	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	71.71	34.08	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	48.49	48.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	71.08	23.69	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	70.69	34.13	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	72.89	32.23	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	69.90	35.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	52.99	39.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	75.79	35.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	84.08	39.75	0.31
Adipocyte - breast, donor1	11376-118A8	41.97	13.94	1.43
Adipocyte - breast, donor2	11327-117E4	38.98	13.48	1.12
Adipocyte - omental, donor1	11473-119C6	44.66	14.12	1.27
Adipocyte - omental, donor2	11474-119C7	40.36	12.71	0.75
Adipocyte - omental, donor3	11475-119C8	42.53	13.06	2.34
Adipocyte - perirenal, donor1	11476-119C9	56.14	19.14	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	16.49	13.19	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	32.52	12.65	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	27.46	15.29	2.09
Adipocyte differentiation, day04, donor1	13019-139D4	28.55	9.58	1.17
Adipocyte differentiation, day04, donor2	13022-139D7	25.48	10.30	0.77
Adipocyte differentiation, day04, donor3	13025-139E1	21.19	13.38	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	32.92	5.29	2.94
Adipocyte differentiation, day08, donor1	13020-139D5	38.69	13.27	9.73
Adipocyte differentiation, day08, donor2	13023-139D8	26.47	11.94	1.61
Adipocyte differentiation, day08, donor3	13026-139E2	30.39	9.06	4.27
Adipocyte differentiation, day08, donor4	13029-139E5	32.83	11.69	5.56
Adipocyte differentiation, day12, donor1	13021-139D6	55.73	26.62	7.90
Adipocyte differentiation, day12, donor2	13024-139D9	35.16	10.55	2.26
Adipocyte differentiation, day12, donor3	13027-139E3	33.38	15.05	6.54
Adipocyte differentiation, day12, donor4	13030-139E6	35.62	11.57	8.22
Alveolar Epithelial Cells, donor1	11510-119G7	32.93	17.90	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	31.56	27.25	1.43
Alveolar Epithelial Cells, donor3	11671-122G6	23.96	7.19	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	32.74	10.97	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	51.88	13.39	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	28.15	13.56	0.00
Anulus Pulposus Cell, donor1	11248-116E6	30.32	8.70	0.57
Anulus Pulposus Cell, donor2	11463-119B5	44.82	12.49	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	31.90	11.23	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	32.56	11.29	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	17.12	14.98	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	29.00	9.57	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	17.71	13.91	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	30.36	8.58	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	31.51	11.05	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	33.01	12.62	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	24.35	10.10	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	29.38	9.79	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	23.22	10.16	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	21.31	11.28	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	23.23	7.58	0.66
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	28.66	9.55	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	35.29	10.10	0.90
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	26.79	7.50	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	29.10	11.71	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	28.60	9.09	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	30.24	11.71	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	25.21	10.78	0.66
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	24.01	9.61	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	31.86	14.16	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	30.70	12.86	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	33.01	9.71	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	31.87	15.94	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	19.38	6.06	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	26.22	11.40	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	23.73	10.05	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	25.55	10.32	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	34.25	10.79	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	32.80	10.93	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	30.68	8.56	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	30.42	12.87	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	32.52	11.44	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	45.14	17.82	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	27.97	11.19	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	29.03	11.21	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	31.13	12.07	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	29.34	9.49	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	31.75	12.49	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	31.03	11.31	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	38.73	12.28	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	27.12	12.04	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	44.01	13.90	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	40.14	8.45	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	30.02	13.29	0.86
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	25.27	9.63	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	34.99	11.66	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	29.19	12.41	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	22.95	20.40	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	30.76	6.86	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	30.97	12.59	0.83
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	32.44	12.85	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	28.68	16.25	1.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	27.72	12.42	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	36.62	10.68	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	29.36	13.85	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	30.72	9.80	0.79
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	32.35	14.17	0.73
Astrocyte - cerebellum, donor1	11500-119F6	48.76	13.88	0.37
Astrocyte - cerebellum, donor2	11580-120F5	56.14	22.59	0.34
Astrocyte - cerebellum, donor3	11661-122F5	30.83	13.84	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	66.93	17.78	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	68.75	23.13	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	71.30	27.74	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	76.27	56.43	0.23
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	78.80	56.63	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	75.45	51.66	0.00
Basophils, donor1	12241-129G9	20.92	14.65	5.75
Basophils, donor2	12242-129H1	22.01	20.57	5.41
Basophils, donor3	12243-129H2	26.17	15.73	2.50
Bronchial Epithelial Cell, donor1	11511-119G8	22.42	13.58	1.08
Bronchial Epithelial Cell, donor2	11591-120G7	26.06	17.37	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	28.69	21.52	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	32.01	21.97	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	34.73	19.96	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	22.34	14.74	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	34.37	23.39	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	44.83	47.10	1.65
Burkitt's lymphoma cell line:RAJI	10476-106I8	72.20	60.55	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	65.55	49.57	2.24
CD133+ stem cells - cord blood derived, pool1	12223-129E9	62.05	31.03	0.00
CD14+ Monocytes, donor1	11224-116B9	27.05	10.71	3.38
CD14+ Monocytes, donor2	11305-117B9	32.85	26.36	1.86
CD14+ Monocytes, donor3	11381-118B4	36.88	29.42	3.07
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	64.82	24.91	3.68
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	55.72	29.57	2.65
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	79.88	28.93	5.59
CD14+ monocytes - mock treated, donor1	11863-125A9	35.85	30.93	7.37
CD14+ monocytes - mock treated, donor2	11873-125C1	34.40	37.11	4.53
CD14+ monocytes - mock treated, donor3	11883-125D2	32.45	28.43	9.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	26.95	21.76	8.37
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	26.22	32.85	9.38
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	33.47	28.76	7.19
CD14+ monocytes - treated with BCG, donor1	11860-125A6	27.41	19.78	8.81
CD14+ monocytes - treated with BCG, donor2	11870-125B7	27.95	20.65	6.05
CD14+ monocytes - treated with BCG, donor3	11880-125C8	33.95	17.19	12.84
CD14+ monocytes - treated with Candida, donor1	11868-125B5	22.94	23.41	4.21
CD14+ monocytes - treated with Candida, donor2	11878-125C6	25.87	27.99	3.17
CD14+ monocytes - treated with Candida, donor3	11888-125D7	36.61	29.95	9.98
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	29.45	23.06	4.91
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	32.13	29.33	7.58
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	31.44	25.82	7.50
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	20.59	22.19	7.09
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	24.43	19.00	8.14
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	23.57	27.06	6.98
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	34.43	21.79	9.68
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	39.25	30.36	7.68
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	42.08	35.35	8.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	22.60	19.84	5.70
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	18.32	26.77	5.99
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	19.30	25.01	7.90
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	28.25	25.11	8.02
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	31.59	34.19	6.69
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	28.67	25.22	10.56
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	29.89	19.66	4.50
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	16.46	15.07	6.03
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	22.74	17.86	5.80
CD14+CD16+ Monocytes, donor1	11789-124B7	48.17	22.89	2.62
CD14+CD16+ Monocytes, donor2	11801-124D1	49.43	23.56	1.62
CD14+CD16+ Monocytes, donor3	11912-125G4	50.25	24.69	2.17
CD14+CD16- Monocytes, donor1	11788-124B6	58.71	25.07	2.65
CD14+CD16- Monocytes, donor2	11799-124C8	56.58	31.09	1.40
CD14+CD16- Monocytes, donor3	11910-125G2	61.54	27.20	2.90
CD14-CD16+ Monocytes, donor1	11790-124B8	55.37	22.20	4.85
CD14-CD16+ Monocytes, donor2	11800-124C9	41.50	18.00	3.29
CD14-CD16+ Monocytes, donor3	11911-125G3	49.90	23.16	3.16
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	26.42	18.29	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	44.07	15.59	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	48.67	17.61	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	45.84	25.05	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	64.33	23.05	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	38.61	24.57	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	35.30	17.26	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	40.87	14.50	0.00
CD19+ B Cells, donor1	11544-120B5	53.42	32.88	6.58
CD19+ B Cells, donor2	11624-122B4	59.49	33.37	3.63
CD19+ B Cells, donor3	11705-123B4	64.62	32.81	5.55
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	52.53	30.30	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	43.94	31.56	0.00
CD34+ Progenitors, donor1	11545-120B6	43.17	16.06	0.00
CD34+ Progenitors, donor2	11625-122B5	41.01	30.34	1.69
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	55.61	43.21	1.13
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	57.50	50.51	1.80
CD4+ T Cells, donor1	11225-116C1	49.99	26.07	2.86
CD4+ T Cells, donor2	11306-117C1	36.74	28.78	1.84
CD4+ T Cells, donor3	11382-118B5	39.34	21.65	3.05
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	55.13	29.86	0.77
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	57.05	39.75	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	55.77	30.47	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	40.77	22.28	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	48.46	26.69	2.11
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	49.44	29.67	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	43.07	23.56	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	65.07	46.26	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	63.68	38.53	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	39.90	22.41	3.14
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	47.17	24.11	1.75
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	38.28	27.72	2.20
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	65.35	29.09	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	63.16	51.11	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	79.19	52.46	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	59.83	20.40	0.82
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	64.31	28.41	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	35.86	41.24	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	63.79	32.64	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	60.22	33.58	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	56.11	43.50	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	30.84	21.74	1.01
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	45.49	26.86	2.60
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	47.94	30.51	3.92
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	53.94	31.18	1.98
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	57.24	28.62	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	44.67	20.94	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	64.52	35.45	0.83
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	75.33	38.77	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	52.36	33.88	3.08
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	40.11	29.72	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	44.32	24.93	2.77
CD8+ T Cells, donor1	11226-116C2	29.79	21.61	1.64
CD8+ T Cells, donor2	11307-117C2	22.90	28.91	1.88
CD8+ T Cells, donor3	11383-118B6	39.39	34.34	3.79
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	48.17	32.80	1.61
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	48.41	31.87	0.72
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	40.22	26.26	1.92
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	37.23	26.72	2.10
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	48.72	29.52	2.64
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	51.62	39.11	2.73
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	50.41	42.15	4.13
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	59.22	37.11	3.42
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	59.33	37.99	3.28
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	57.05	43.77	3.02
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	63.62	40.96	3.49
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	48.49	46.89	2.13
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	36.77	31.08	5.69
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	37.80	35.07	6.38
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	39.53	29.83	5.97
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	42.50	42.86	3.24
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	46.04	34.24	4.89
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	47.38	30.64	2.59
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	50.07	26.94	5.07
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	67.05	36.29	6.46
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	52.26	33.98	2.89
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	47.81	43.22	3.82
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	57.54	42.56	4.73
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	46.90	41.60	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	23.29	18.47	4.82
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	34.27	30.77	2.10
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	34.06	29.05	3.01
Cardiac Myocyte, donor1	11525-119I4	25.59	3.66	0.00
Cardiac Myocyte, donor2	11605-120I3	35.57	23.72	0.49
Cardiac Myocyte, donor3	11686-122I3	29.89	10.10	0.11
Chondrocyte - de diff, donor1	11261-116G1	90.13	24.61	0.69
Chondrocyte - de diff, donor2	11338-117F6	25.94	9.24	0.36
Chondrocyte - de diff, donor3	11410-118E6	27.99	14.22	1.37
Chondrocyte - re diff, donor2	11339-117F7	42.08	13.43	0.90
Chondrocyte - re diff, donor3	11411-118E7	28.71	13.35	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	54.28	21.12	0.46
Ciliary Epithelial Cells, donor2	11323-117D9	40.83	16.89	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	44.51	20.53	0.44
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	45.02	12.75	1.93
Corneal Epithelial Cells, donor1	11526-119I5	16.25	7.69	0.00
Corneal Epithelial Cells, donor2	11606-120I4	31.85	18.20	0.00
Corneal Epithelial Cells, donor3	11687-122I4	34.00	27.10	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	43.09	16.67	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	41.00	19.24	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	58.66	13.80	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	48.49	21.92	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	66.62	35.53	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	61.37	41.13	1.31
Dendritic Cells - plasmacytoid, donor3	11385-118B8	79.37	45.01	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	25.68	10.34	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	31.10	23.47	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	31.11	10.75	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	38.53	15.33	0.39
Endothelial Cells - Artery, donor1	11264-116G4	22.11	22.98	0.29
Endothelial Cells - Artery, donor2	11341-117F9	34.59	15.53	0.00
Endothelial Cells - Artery, donor3	11413-118E9	34.71	23.14	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	33.69	8.87	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	41.08	14.00	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	42.85	14.94	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	35.95	9.51	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	16.14	11.98	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	21.84	12.62	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	72.42	25.61	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	27.25	7.86	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	56.04	26.46	0.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	35.41	16.51	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	42.13	23.20	0.00
Endothelial Cells - Vein, donor1	11267-116G7	31.85	17.06	0.00
Endothelial Cells - Vein, donor2	11344-117G3	19.56	6.99	0.00
Endothelial Cells - Vein, donor3	11416-118F3	33.60	18.84	0.16
Eosinophils, donor1	12244-129H3	30.49	45.74	0.00
Eosinophils, donor2	12245-129H4	1.65	3.30	0.00
Eosinophils, donor3	12246-129H5	7.13	3.57	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	18.81	10.99	0.73
Esophageal Epithelial Cells, donor2	11587-120G3	27.04	14.56	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	43.93	18.47	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	33.61	18.18	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	60.13	26.00	0.22
Fibroblast - Aortic Adventitial, donor1	11245-116E3	47.54	12.49	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	13.51	4.91	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	36.70	14.66	0.42
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	32.15	8.70	1.05
Fibroblast - Aortic Adventitial, donor3	11401-118D6	42.19	15.61	0.33
Fibroblast - Cardiac, donor1	11268-116G8	32.21	17.69	0.00
Fibroblast - Cardiac, donor2	11345-117G4	25.01	7.58	0.00
Fibroblast - Cardiac, donor3	11417-118F4	18.14	10.57	0.00
Fibroblast - Cardiac, donor4	11452-119A3	44.25	11.21	0.00
Fibroblast - Cardiac, donor5	11456-119A7	57.23	25.13	0.00
Fibroblast - Cardiac, donor6	11460-119B2	65.19	20.77	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	37.92	9.51	0.54
Fibroblast - Choroid Plexus, donor2	11572-120E6	32.36	15.53	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	54.20	30.76	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	43.82	19.37	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	24.08	9.50	0.34
Fibroblast - Dermal, donor1	11269-116G9	52.83	34.04	0.47
Fibroblast - Dermal, donor2	11346-117G5	32.07	15.57	0.00
Fibroblast - Dermal, donor3	11418-118F5	49.93	29.13	0.48
Fibroblast - Dermal, donor4	11450-119A1	72.91	29.96	0.00
Fibroblast - Dermal, donor5	11454-119A5	91.06	43.96	0.35
Fibroblast - Dermal, donor6	11458-119A9	98.75	51.65	0.16
Fibroblast - Gingival, donor1	11237-116D4	43.10	10.20	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	47.42	17.29	0.00
Fibroblast - Gingival, donor2	11318-117D4	51.66	25.83	0.00
Fibroblast - Gingival, donor3	11394-118C8	44.48	22.82	0.39
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	36.36	13.51	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	33.30	9.51	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	56.75	19.33	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	52.20	22.45	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	44.46	14.12	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	54.55	22.96	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	48.95	15.41	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	77.55	27.75	0.33
Fibroblast - Gingival, donor9 (control)	11927-125I1	32.14	8.80	0.15
Fibroblast - Lung, donor1	11270-116H1	20.39	8.16	0.00
Fibroblast - Lung, donor2	11347-117G6	46.26	5.97	1.49
Fibroblast - Lung, donor3	11419-118F6	33.77	14.56	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	55.81	14.16	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	25.18	22.38	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	29.39	10.92	0.00
Fibroblast - Mammary, donor1	11540-120B1	66.98	30.04	0.41
Fibroblast - Mammary, donor2	11620-122A9	63.91	47.93	0.00
Fibroblast - Mammary, donor3	11701-123A9	35.74	29.78	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	54.70	21.14	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	68.86	33.98	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	67.62	24.78	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	34.73	14.12	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	35.64	14.85	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	32.94	11.13	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	40.90	12.16	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	52.22	21.94	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	33.41	20.05	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	34.00	15.02	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	21.04	7.14	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	32.50	9.77	0.89
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	45.13	13.20	0.59
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	29.18	12.64	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	51.82	18.78	0.86
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	15.94	5.06	0.51
Fibroblast - skin normal, donor1	11553-120C5	39.71	12.47	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	23.46	6.82	0.00
Fibroblast - skin normal, donor2	11561-120D4	41.39	12.66	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	15.72	5.14	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	39.52	11.52	0.91
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	47.52	12.14	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	28.25	10.18	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	52.52	14.91	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	41.66	14.68	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	31.52	17.09	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	221.60	110.80	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	70.59	31.38	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	30.16	10.75	1.04
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	32.53	15.35	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	36.28	15.84	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	70.43	54.35	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	72.10	52.32	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	118.10	107.54	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	125.19	90.72	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	92.24	52.06	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	111.15	93.91	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	114.99	87.23	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	127.52	67.51	1.30
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	105.25	102.60	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	61.33	36.18	0.28
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	58.37	33.62	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	60.71	48.35	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	51.66	32.09	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	56.75	30.32	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	47.98	31.92	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	45.41	28.98	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	41.98	24.17	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	43.28	27.76	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	55.55	30.14	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	53.89	26.86	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	51.39	30.16	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	44.36	28.43	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	57.85	24.43	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	61.89	21.72	0.18
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	60.66	24.04	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	57.72	28.52	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	52.12	27.66	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	52.16	20.80	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	54.72	25.93	1.02
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	42.71	25.99	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	52.69	25.25	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	43.69	28.35	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	39.46	30.20	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	46.86	29.40	0.37
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	48.63	30.31	0.97
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	54.20	28.86	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	44.53	22.08	0.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	40.49	29.10	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	54.43	28.89	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	39.10	19.97	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	39.30	27.66	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	44.89	31.98	1.40
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	42.78	19.72	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	41.18	25.67	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	46.67	30.45	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	41.19	23.32	0.91
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	47.98	33.34	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	30.60	16.59	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	36.41	15.79	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	44.63	24.79	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	34.03	17.15	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	27.64	14.53	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	61.51	21.35	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	76.84	41.21	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	62.86	35.90	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	85.92	47.26	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	59.46	41.62	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	66.97	39.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	89.47	56.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	74.24	79.19	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	63.44	42.94	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	70.60	65.78	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	53.90	55.64	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	64.77	48.82	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	62.18	35.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	113.30	93.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	56.77	41.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	58.50	44.12	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	71.30	62.91	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	62.02	52.80	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	67.93	42.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	89.79	50.12	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	73.88	61.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	44.99	40.55	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	59.30	49.13	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	59.65	33.55	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	71.11	41.42	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	94.83	73.76	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	48.44	40.75	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	49.22	37.81	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	76.92	61.53	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	51.63	34.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	63.33	42.11	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	84.48	86.97	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	71.72	54.73	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	51.90	36.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	74.78	65.62	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	65.81	52.25	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	46.87	44.90	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	66.10	49.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	44.93	44.93	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	54.86	37.74	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	44.08	47.47	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	38.80	29.25	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	33.97	25.23	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	26.25	13.70	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	17.46	8.73	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	29.24	16.87	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	31.72	13.64	2.22
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	27.99	17.13	2.09
Hep-2 cells mock treated, biol_rep1	11898-125E8	82.74	46.30	0.35
Hep-2 cells mock treated, biol_rep2	11899-125E9	91.49	55.03	0.68
Hep-2 cells mock treated, biol_rep3	11900-125F1	80.76	53.69	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	74.66	42.30	0.33
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	88.11	56.95	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	78.58	43.92	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	73.85	48.07	0.50
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	85.09	51.81	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	66.96	56.71	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	53.72	25.18	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	39.38	19.04	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	44.94	29.08	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	31.04	12.70	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	39.96	13.08	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	35.49	17.13	0.35
Hepatocyte, donor1	11523-119I2	43.58	7.26	3.63
Hepatocyte, donor2	11603-120I1	50.63	34.47	8.62
Hepatocyte, donor3	11684-122I1	33.13	17.79	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	33.29	26.76	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	44.04	29.19	3.32
Iris Pigment Epithelial Cells, donor1	11530-119I9	32.93	13.45	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	12.74	15.92	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	26.70	6.68	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	24.92	27.69	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	12.51	15.02	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	35.60	47.47	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	20.50	28.19	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	27.42	13.71	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	30.86	17.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	26.68	16.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	10.89	25.41	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	14.56	25.15	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	23.28	21.06	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	36.67	15.71	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	23.30	19.53	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	34.03	29.39	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	87.81	58.54	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	25.84	16.15	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	37.03	25.76	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	47.79	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	30.15	15.48	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	9.66	7.14	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	28.74	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	28.93	16.07	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	18.47	24.01	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	60.32	15.08	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	33.51	25.49	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	18.14	23.58	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	58.97	44.23	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	29.06	21.52	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	33.03	25.41	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	65.72	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	17.22	10.20	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	21.87	23.69	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	79.02	15.80	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	17.85	15.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	19.91	29.86	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	41.70	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	30.25	19.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	33.36	22.83	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	25.15	12.57	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	26.42	20.17	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	17.70	13.28	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	29.18	58.36	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	20.93	11.34	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	29.25	20.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	20.91	17.42	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	14.93	14.93	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	16.63	12.47	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	34.20	25.65	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	19.33	17.49	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	24.20	24.20	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	12.42	12.42	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	13.75	19.03	0.00
Keratinocyte - epidermal, donor1	11272-116H3	27.25	12.24	0.24
Keratinocyte - epidermal, donor2	11349-117G8	8.20	2.34	0.00
Keratinocyte - epidermal, donor3	11421-118F8	46.48	28.96	0.09
Keratinocyte - oral, donor1	11251-116E9	56.30	24.18	0.68
Keratocytes, donor1	11527-119I6	55.70	20.97	0.34
Keratocytes, donor2	11607-120I5	50.39	35.15	0.00
Keratocytes, donor3	11688-122I5	59.87	28.06	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	30.77	10.99	0.00
Lens Epithelial Cells, donor1	11529-119I8	45.31	29.13	0.00
Lens Epithelial Cells, donor2	11609-120I7	44.29	15.45	0.81
Lens Epithelial Cells, donor3	11690-122I7	43.49	13.22	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	31.42	10.43	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	27.07	9.77	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	38.72	14.48	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	24.73	11.83	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	24.90	10.09	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	21.02	9.06	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	24.21	10.67	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	22.00	11.12	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	23.36	8.45	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	22.15	9.89	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	28.31	14.15	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	13.70	8.15	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	26.48	12.54	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	24.81	10.73	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	23.35	7.97	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	21.25	8.01	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	18.08	9.98	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	21.41	8.97	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	27.32	8.56	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	24.89	7.03	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	16.68	8.21	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	29.10	19.40	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	26.12	11.31	1.35
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	26.04	11.66	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	29.03	8.81	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	28.90	11.10	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	24.96	7.37	0.90
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	22.01	16.51	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	22.77	9.60	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	17.92	7.95	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	21.32	11.15	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	22.49	11.25	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	19.20	8.80	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	29.99	12.59	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	26.44	11.86	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	19.80	8.94	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	32.49	17.05	1.29
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	33.48	11.87	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	31.63	12.32	0.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	19.56	14.22	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	26.18	7.76	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	18.67	8.09	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	27.22	14.68	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	24.17	11.43	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	18.60	6.12	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	27.35	8.42	0.37
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	19.47	10.50	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	19.69	9.25	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	38.52	11.33	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	54.47	24.55	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	37.11	23.75	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	51.20	20.73	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	33.76	34.46	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	36.42	28.02	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	26.79	13.91	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	40.44	30.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	26.69	9.27	0.68
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	52.35	24.72	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	45.47	27.01	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	32.52	12.60	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	43.14	29.78	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	48.69	29.64	1.06
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	51.97	34.65	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	51.96	35.66	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	54.70	28.55	1.60
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	45.54	27.59	0.57
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	56.45	22.70	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	48.93	35.88	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	50.81	21.45	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	65.02	32.79	1.40
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	44.30	31.94	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	39.77	23.51	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	59.49	27.50	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	61.41	36.51	1.66
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	41.00	26.16	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	57.16	35.77	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	37.99	13.82	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	46.43	21.87	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	40.20	22.65	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	49.23	26.25	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	38.41	25.76	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	40.93	32.32	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	56.02	35.85	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	44.22	19.69	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	46.09	26.28	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	41.96	41.10	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	40.65	23.99	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	44.04	17.50	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	44.08	18.49	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	29.56	18.90	1.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	42.40	26.30	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	34.34	25.59	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	43.34	22.59	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	43.03	13.96	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	42.31	20.10	2.12
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	42.82	23.61	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	50.15	23.26	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	42.16	25.30	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	39.46	24.17	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	44.22	29.17	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	41.73	22.63	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	33.80	26.14	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	17.21	15.49	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	53.44	28.06	1.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	45.75	19.94	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	36.95	27.71	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	51.89	20.24	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	38.07	25.82	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	60.38	31.87	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	48.58	29.15	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	48.60	23.91	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	47.09	21.77	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	54.31	27.88	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	40.55	21.87	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	56.51	27.95	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	51.88	27.67	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	42.56	17.86	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	54.22	26.85	1.03
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	62.88	40.51	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	47.22	23.77	1.58
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	61.84	36.25	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	60.34	28.73	1.72
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	38.05	25.71	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	46.69	22.64	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	52.78	26.10	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	42.85	21.22	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	54.03	32.10	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	52.19	32.99	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	49.72	24.16	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	52.19	28.10	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	58.81	37.96	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	39.20	23.44	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	37.63	20.19	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	44.46	40.01	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	54.71	28.49	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	57.52	30.68	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	71.13	35.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	44.54	24.95	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	35.61	14.82	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	65.65	33.82	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	62.36	22.86	0.00
Macrophage - monocyte derived, donor1	11232-116C8	57.89	9.34	0.46
Macrophage - monocyte derived, donor2	11313-117C8	46.43	16.70	0.55
Macrophage - monocyte derived, donor3	11389-118C3	70.91	27.53	0.79
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	20.71	7.43	0.00
Mallassez-derived cells, donor2	11929-125I3	35.02	13.31	0.16
Mallassez-derived cells, donor3	11930-125I4	41.00	18.49	0.28
Mammary Epithelial Cell, donor1	11273-116H4	48.83	26.41	0.30
Mammary Epithelial Cell, donor2	11350-117G9	32.43	26.93	0.00
Mammary Epithelial Cell, donor3	11422-118F9	22.95	20.95	0.00
Mast cell - stimulated, donor1	11487-119E2	124.74	58.30	0.68
Mast cell, donor1	11563-120D6	72.13	37.31	0.43
Mast cell, donor2	11565-120D8	62.41	30.31	0.89
Mast cell, donor3	11566-120D9	83.75	36.92	1.58
Mast cell, donor4	11567-120E1	60.81	34.39	1.60
Mast cell, expanded and stimulated, donor5	11940-126A5	102.69	48.90	1.33
Mast cell, expanded and stimulated, donor8	11942-126A7	98.64	36.77	2.92
Mast cell, expanded, donor5	11939-126A4	82.26	31.43	0.69
Mast cell, expanded, donor8	11941-126A6	75.98	40.17	1.67
Melanocyte - dark, donor1	11502-119F8	40.79	15.02	0.20
Melanocyte - dark, donor2	11582-120F7	28.38	21.11	0.35
Melanocyte - dark, donor3	11663-122F7	72.08	30.14	0.94
Melanocyte - light, donor1	11274-116H5	29.85	10.81	0.47
Melanocyte - light, donor2	11351-117H1	11.60	4.78	0.00
Melanocyte - light, donor3	11423-118G1	14.74	4.34	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	59.66	28.01	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	51.64	23.67	0.81
Melanocyte, donor3 (MC+3)	12837-137B2	62.68	39.91	0.80
Meningeal Cells, donor1	11493-119E8	69.47	17.49	0.37
Meningeal Cells, donor2	11573-120E7	80.99	29.05	0.44
Meningeal Cells, donor3	11654-122E7	72.54	19.15	0.41
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	47.62	14.54	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	37.13	9.66	1.21
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	10.51	7.88	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	52.33	15.70	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	49.51	23.68	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	38.33	13.34	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	44.23	22.12	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	37.14	19.78	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	61.37	37.26	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	49.72	29.26	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	41.28	11.77	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	16.36	8.55	1.12
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	44.87	17.37	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	13.06	9.50	0.89
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	14.01	18.68	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	37.14	23.05	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	46.43	17.72	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	35.03	10.95	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	46.44	30.48	0.00
Mesothelial Cells, donor1	11247-116E5	39.78	9.28	1.33
Mesothelial Cells, donor2	12156-128G5	26.52	5.00	0.00
Mesothelial Cells, donor3	11402-118D7	38.73	10.26	0.72
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	2.70	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	70.43	26.35	0.99
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	61.84	15.02	1.18
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	13.83	0.00	3.46
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	67.26	27.59	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	47.29	18.46	0.62
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	11.58	4.63	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	57.06	30.28	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	41.89	11.64	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	51.82	24.18	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	39.60	13.86	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	53.98	29.20	1.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	62.69	19.38	1.14
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	14.47	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	53.06	23.56	1.27
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	23.02	4.60	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	44.11	22.06	1.19
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	6.71	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	56.96	30.86	1.76
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	41.83	16.87	0.95
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	12.72	3.87	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	53.42	24.87	1.38
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	46.70	13.67	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	41.38	22.62	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	52.13	29.39	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	34.90	11.11	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	38.98	19.93	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	19.77	5.07	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	14.91	4.97	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	28.81	16.04	1.36
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	42.94	12.06	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	6.54	4.36	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	48.06	21.62	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	47.63	13.21	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	10.97	4.11	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	48.56	31.04	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	134.74	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	8.15	2.04	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	43.35	27.15	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	8.83	2.21	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	10.89	3.84	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	50.33	22.56	0.74
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	13.92	6.26	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	15.47	6.63	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	38.29	18.12	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	15.32	4.81	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	4.97	2.13	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	40.68	23.29	0.84
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	26.60	7.07	0.83
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	9.32	1.75	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	26.24	17.50	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	40.90	19.62	1.67
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	7.22	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	17.55	10.16	3.69
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	34.15	17.64	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	15.48	7.05	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	34.99	18.92	1.55
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	30.03	9.87	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	10.16	3.81	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	17.35	8.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	52.68	19.76	1.50
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	19.35	7.63	0.42
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	42.04	14.97	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	40.02	16.81	0.88
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	12.51	3.79	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	31.54	16.48	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	61.21	22.86	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	14.34	3.26	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	27.93	13.53	1.18
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	49.02	17.88	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	15.25	4.95	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	27.99	12.80	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	169.51	101.71	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	149.71	90.89	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	137.01	66.37	1.64
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	122.03	74.69	5.26
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	87.18	29.85	1.98
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	94.06	51.22	4.66
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	164.11	76.61	1.88
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	96.42	49.54	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	52.82	22.73	2.15
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	115.67	70.73	3.68
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	131.91	64.49	2.56
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	99.56	51.33	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	99.94	39.01	4.81
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	150.69	88.87	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	149.47	69.69	3.03
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	136.19	60.29	2.11
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	141.64	54.48	4.09
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	113.81	63.58	2.54
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	145.77	67.22	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	231.10	131.41	4.53
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	39.97	28.55	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	75.04	58.72	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	28.51	14.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	225.88	50.20	12.55
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	38.56	12.50	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	38.15	18.29	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	80.77	26.03	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	40.07	22.96	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	69.02	33.85	0.57
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	35.11	11.17	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	74.79	23.80	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	62.48	36.75	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	73.24	28.04	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	89.26	33.24	0.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	61.34	20.00	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	45.20	13.24	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	33.40	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	60.06	27.30	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	46.28	33.02	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	61.66	23.57	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	62.22	14.53	0.65
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	40.28	15.86	0.73
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	74.79	20.16	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	64.83	17.41	1.80
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	25.60	18.38	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	62.28	22.93	0.65
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	27.69	9.88	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	90.72	43.60	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	58.84	25.28	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	85.80	31.17	0.96
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	42.77	21.73	1.03
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	30.34	32.87	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	36.54	10.03	0.89
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	75.79	34.29	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	45.81	19.94	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	103.88	37.34	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	99.31	54.17	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	77.97	28.66	0.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	26.15	7.21	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	82.53	29.36	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	67.79	38.07	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	63.57	42.38	1.14
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	77.56	23.79	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	41.84	16.56	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	28.95	10.40	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	76.73	39.69	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	75.13	29.92	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	97.72	39.68	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	61.25	18.76	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	32.97	22.38	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	40.67	16.13	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	92.16	39.30	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	91.97	30.66	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	95.72	32.92	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	54.13	20.77	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	44.19	13.62	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	61.71	29.27	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	40.81	30.61	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	60.69	20.23	0.00
Myoblast, donor1	11241-116D8	38.14	14.16	0.50
Myoblast, donor2	11322-117D8	56.39	23.40	0.38
Myoblast, donor3	11398-118D3	55.16	17.66	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	113.10	132.07	1.31
Natural Killer Cells, donor1	11230-116C6	23.06	20.30	1.54
Natural Killer Cells, donor2	11311-117C6	24.12	27.44	3.92
Natural Killer Cells, donor3	11387-118C1	24.85	27.79	2.76
Neural stem cells, donor1	11275-116H6	150.62	35.93	4.72
Neural stem cells, donor2	11352-117H2	161.75	46.22	1.93
Neurons, donor1	11494-119E9	89.89	50.07	3.41
Neurons, donor2	11574-120E8	87.40	25.32	1.76
Neurons, donor3	11655-122E8	113.46	55.09	5.76
Neutrophils, donor1	11233-116C9	11.14	0.93	0.00
Neutrophils, donor2	11314-117C9	28.99	5.80	0.00
Neutrophils, donor3	11390-118C4	21.38	4.89	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	32.41	9.62	0.36
Nucleus Pulposus Cell, donor2	11409-118E5	24.75	16.28	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	53.55	18.25	0.20
Olfactory epithelial cells, donor1	11933-125I7	52.72	18.58	0.41
Olfactory epithelial cells, donor2	11934-125I8	54.86	17.37	0.29
Olfactory epithelial cells, donor3	11935-125I9	51.08	16.69	0.57
Olfactory epithelial cells, donor4	11936-126A1	58.24	18.60	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	31.29	14.44	1.20
Osteoblast - differentiated, donor1	11276-116H7	20.21	4.89	0.43
Osteoblast - differentiated, donor2	11353-117H3	25.15	11.43	0.00
Osteoblast - differentiated, donor3	11425-118G3	29.79	12.41	0.00
Osteoblast, donor1	11277-116H8	15.63	5.47	0.00
Osteoblast, donor2	11354-117H4	44.95	18.96	0.00
Osteoblast, donor3	11426-118G4	38.21	16.35	0.00
Pancreatic stromal cells, donor1	11249-116E7	44.22	16.26	0.34
Pericytes, donor1	11491-119E6	20.03	6.90	0.11
Pericytes, donor2	11571-120E5	46.86	23.99	0.23
Pericytes, donor3	11652-122E5	43.54	22.58	0.00
Perineurial Cells, donor1	11499-119F5	36.62	12.55	0.11
Perineurial Cells, donor2	11579-120F4	31.93	11.04	0.64
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	46.54	17.85	2.55
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	41.63	23.75	1.96
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	38.57	33.26	0.91
Placental Epithelial Cells, donor1	11278-116H9	12.20	3.35	0.48
Placental Epithelial Cells, donor2	11355-117H5	9.98	4.44	0.00
Placental Epithelial Cells, donor3	11427-118G5	13.74	5.50	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	39.56	15.51	0.00
Preadipocyte - breast, donor1	11467-119B9	34.70	8.25	0.56
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	8.48	2.74	0.26
Preadipocyte - breast, donor2	11328-117E5	32.42	13.28	0.00
Preadipocyte - omental, donor1	11468-119C1	44.12	10.76	1.07
Preadipocyte - omental, donor2	11329-117E6	41.90	9.17	0.44
Preadipocyte - omental, donor3	11403-118D8	43.69	19.63	0.29
Preadipocyte - perirenal, donor1	11469-119C2	29.53	14.76	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	16.89	3.99	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	67.47	21.07	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	42.40	19.41	0.51
Preadipocyte - visceral, donor1	11280-116I2	57.94	19.75	0.37
Preadipocyte - visceral, donor2	11357-117H7	46.94	15.65	0.00
Preadipocyte - visceral, donor3	11429-118G7	53.81	19.64	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	47.22	22.63	3.92
Prostate Epithelial Cells, donor2	11331-117E8	27.90	11.78	0.14
Prostate Epithelial Cells, donor3	11404-118D9	36.74	24.07	0.55
Prostate Stromal Cells, donor1	11254-116F3	44.76	13.90	0.34
Prostate Stromal Cells, donor2	11332-117E9	54.87	24.38	0.00
Prostate Stromal Cells, donor3	11405-118E1	31.28	14.49	0.21
Renal Cortical Epithelial Cells, donor1	11516-119H4	24.09	20.07	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	33.89	12.20	0.35
Renal Epithelial Cells, donor1	11517-119H5	20.29	16.74	0.00
Renal Epithelial Cells, donor2	11597-120H4	33.43	27.03	0.00
Renal Epithelial Cells, donor3	11678-122H4	40.12	17.04	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	54.47	22.47	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	51.21	31.67	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	57.94	27.53	0.67
Renal Glomerular Endothelial Cells, donor4	11783-124B1	30.61	10.65	0.00
Renal Mesangial Cells, donor1	11518-119H6	26.63	11.22	0.22
Renal Mesangial Cells, donor2	11598-120H5	35.74	24.45	0.63
Renal Mesangial Cells, donor3	11679-122H5	20.53	13.87	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	41.07	17.18	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	34.58	35.84	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	38.18	19.86	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	40.97	22.30	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	31.27	19.90	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	40.14	24.70	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	53.19	18.07	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	44.37	10.16	2.94
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	47.35	20.55	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	29.72	20.36	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	26.10	16.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	38.36	12.09	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	42.90	14.80	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	44.95	15.62	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	41.06	18.61	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	50.35	17.25	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	53.85	25.42	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	54.90	26.70	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	38.42	14.67	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	39.06	16.49	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	54.80	30.99	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	40.03	16.96	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	47.57	21.91	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	41.29	24.47	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	38.38	16.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	52.43	18.04	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	51.49	19.11	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	37.87	14.02	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	49.46	22.92	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	45.60	20.40	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	38.40	18.50	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	45.46	20.85	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	50.32	20.42	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	41.20	17.05	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	50.64	22.16	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	55.19	33.26	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	40.87	16.67	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	44.20	25.26	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	52.46	32.97	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	44.68	18.80	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	44.70	19.64	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	59.49	29.20	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	32.36	11.41	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	46.08	19.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	56.05	33.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	38.96	12.89	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	45.80	17.07	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	48.40	26.25	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	42.61	17.46	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	41.32	20.79	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	50.47	28.34	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	38.57	18.33	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	49.18	24.79	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	42.94	23.26	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	42.27	17.82	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	34.45	17.53	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	50.55	26.19	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	59.68	22.27	0.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	45.02	28.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	60.58	32.25	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	35.06	22.85	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	53.02	30.25	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	43.57	20.66	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	40.98	22.20	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	39.66	31.85	0.00
Schwann Cells, donor1	11498-119F4	51.16	25.01	0.19
Schwann Cells, donor2	11578-120F3	51.04	40.83	0.00
Schwann Cells, donor3	11659-122F3	29.14	16.21	0.22
Sebocyte, donor1	11220-116B5	34.51	17.53	0.55
Sebocyte, donor2	11301-117B5	39.52	14.71	0.92
Sebocyte, donor3	11378-118B1	27.62	11.95	0.00
Sertoli Cells, donor1	11255-116F4	44.73	13.25	0.00
Sertoli Cells, donor2	11333-117F1	39.54	5.65	0.00
Skeletal Muscle Cells, donor1	11281-116I3	40.03	11.96	0.26
Skeletal Muscle Cells, donor2	11358-117H8	28.91	15.18	0.00
Skeletal Muscle Cells, donor3	11430-118G8	40.97	10.87	0.00
Skeletal Muscle Cells, donor4	11451-119A2	67.86	32.36	0.16
Skeletal Muscle Cells, donor5	11455-119A6	70.90	30.17	0.74
Skeletal Muscle Cells, donor6	11459-119B1	85.42	43.71	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	39.69	14.11	0.63
Skeletal Muscle Satellite Cells, donor2	11321-117D7	45.23	19.26	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	62.30	32.44	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	30.41	12.81	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	28.95	13.75	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	26.01	9.77	0.14
Skin - palm, donor1	10286-104F7	32.23	0.00	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	42.67	26.38	0.72
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	30.26	17.99	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	51.15	27.39	1.04
Small Airway Epithelial Cells, donor1	11256-116F5	33.36	10.98	2.09
Small Airway Epithelial Cells, donor2	11334-117F2	27.71	13.22	0.98
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	29.39	11.42	2.54
Small Airway Epithelial Cells, donor3	11406-118E2	33.43	15.44	0.97
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	38.57	26.54	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	27.12	10.45	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	21.16	8.23	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	22.76	4.42	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	22.84	5.51	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	23.18	7.73	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	34.03	11.01	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	17.83	5.46	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	37.02	18.62	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	54.41	19.72	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	30.93	7.81	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	36.62	10.04	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	37.73	19.50	0.57
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	28.47	14.15	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	40.19	9.74	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	17.43	3.28	1.01
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	27.66	6.68	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	28.76	10.03	0.88
Smooth Muscle Cells - Colonic, donor2	11320-117D6	41.54	15.07	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	40.93	22.57	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	19.49	6.65	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	36.65	14.01	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	36.16	16.14	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	25.60	14.34	0.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	29.84	10.60	0.79
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	50.52	13.69	0.30
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	43.69	12.74	1.14
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	29.59	11.47	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	73.91	33.38	1.85
Smooth Muscle Cells - Prostate, donor1	11257-116F6	49.54	18.51	0.40
Smooth Muscle Cells - Prostate, donor2	11335-117F3	35.19	11.39	0.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	22.07	4.57	0.76
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	40.41	9.95	0.45
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	24.76	6.00	1.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	25.84	12.92	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	16.28	4.65	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	30.29	10.10	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	41.99	12.85	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	25.07	8.26	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	53.32	18.41	0.50
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	33.17	13.08	1.40
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	16.12	5.90	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	30.59	15.55	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	37.04	15.61	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	43.88	19.14	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	34.10	13.41	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	42.86	17.62	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	15.66	5.14	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	55.02	19.22	0.66
Smooth Muscle Cells - Uterine, donor3	11466-119B8	28.09	11.12	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	30.71	15.16	2.33
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	39.93	13.22	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	21.94	5.95	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	28.03	13.65	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	39.75	18.45	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	50.02	31.90	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	29.97	15.49	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	25.56	14.38	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	40.96	25.50	2.09
Smooth muscle cells - airway, control, donor4	11969-126D7	29.79	14.21	1.83
Synoviocyte, donor1	11291-117A4	40.73	12.29	0.00
Synoviocyte, donor2	11368-117I9	32.69	13.58	0.84
Synoviocyte, donor3	11440-118H9	41.11	15.64	2.01
Trabecular Meshwork Cells, donor1	11532-120A2	44.67	24.66	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	37.66	17.84	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	30.33	16.90	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	24.44	10.47	0.36
Tracheal Epithelial Cells, donor2	11369-118A1	17.01	13.53	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	18.90	20.04	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	38.26	8.61	4.06
Urethra, donor2	10319-105A4	26.98	7.19	0.00
Urothelial Cells, donor1	11520-119H8	24.44	10.10	0.53
Urothelial Cells, donor2	11600-120H7	22.03	8.81	0.40
Urothelial Cells, donor3	11681-122H7	27.28	11.46	0.00
Urothelial cells, donor0	11216-116B1	34.55	17.39	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	43.60	22.24	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	58.61	12.87	2.86
Whole blood (ribopure), donor090309, donation3	12181-129A3	35.60	19.85	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	45.80	15.84	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	41.83	9.30	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	57.27	22.91	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	39.47	12.85	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	36.52	25.56	0.91
Wilms' tumor cell line:G-401	10809-111A8	85.74	48.85	0.12
Wilms' tumor cell line:HFWT	10597-108E3	42.24	2.64	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	48.32	28.77	0.00
achilles tendon, donor2	10292-104G4	33.06	22.73	4.13
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	71.13	53.03	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	76.85	39.70	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	80.60	52.59	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	110.48	70.21	0.82
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	83.48	101.47	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	73.38	41.66	2.75
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	85.75	96.09	1.09
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	106.19	151.58	2.20
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	111.48	119.24	2.45
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	234.92	208.90	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	123.65	124.57	0.74
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	89.71	31.20	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	70.64	69.02	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	112.10	91.65	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	101.41	95.86	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	62.28	40.43	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	82.25	43.59	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	147.03	48.19	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	138.25	50.35	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	111.01	43.67	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	133.35	45.25	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	71.50	73.73	0.67
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	79.72	48.03	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	31.59	16.72	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	105.46	78.35	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	144.36	151.77	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	52.48	37.49	0.00
adenocarcinoma cell line:IM95m	10796-110I4	64.53	57.46	4.71
adipose tissue, adult, pool1	10010-101C1	50.10	12.72	2.79
adipose, donor1	10184-103D4	105.55	77.99	0.00
adipose, donor2	10185-103D5	97.32	58.39	0.00
adipose, donor3	10186-103D6	77.87	50.92	0.27
adipose, donor4	10187-103D7	76.27	35.54	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	167.45	74.65	0.00
adrenal gland, adult, pool1	10081-102A9	90.94	18.19	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	57.63	35.89	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	174.72	55.02	0.00
amniotic membrane cells, donor1	12235-129G3	30.14	8.11	0.23
amniotic membrane cells, donor2	12236-129G4	39.90	9.13	0.34
amniotic membrane cells, donor3	12237-129G5	33.29	8.84	0.00
amygdala - adult, donor10196	10167-103B5	97.24	54.55	1.19
amygdala, adult, donor10252	10151-102I7	63.87	18.45	0.81
amygdala, newborn, donor10223	10360-105E9	73.59	24.21	4.20
anaplastic carcinoma cell line:8305C	10428-106D5	67.99	31.71	0.38
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	196.13	146.49	0.88
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	111.57	48.44	1.00
aorta, adult, pool1	10052-101G7	63.74	15.89	1.57
appendix, adult	10189-103D9	52.01	23.29	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	25.80	20.29	8.25
artery, adult	10190-103E1	59.78	17.66	0.00
astrocytoma cell line:TM-31	10425-106D2	67.51	19.41	0.00
b cell line:RPMI1788	10427-106D4	51.90	33.90	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	29.96	6.66	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	127.22	55.67	0.99
bile duct carcinoma cell line:TFK-1	10496-107C1	34.48	15.06	2.51
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	76.62	109.05	1.12
bladder, adult, pool1	10011-101C2	32.27	9.02	0.54
blood, adult, pool1	10053-101G8	59.79	57.58	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	21.41	6.85	0.00
bone marrow, adult	10192-103E3	58.04	21.59	1.35
brain, adult, donor1	10084-102B3	94.31	35.88	0.00
brain, adult, pool1	10012-101C3	75.17	16.93	0.56
brain, fetal, pool1	10085-102B4	136.24	42.74	0.00
breast carcinoma cell line:MCF7	10482-107A5	31.38	8.59	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	77.64	24.96	9.36
breast, adult, donor1	10080-102A8	73.87	34.09	2.53
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	96.29	51.58	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	59.06	28.76	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	81.27	41.90	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	69.24	29.05	0.48
carcinoid cell line:NCI-H1770	10703-109H1	71.94	46.08	0.00
carcinoid cell line:NCI-H727	10735-110B6	37.08	19.36	2.73
carcinoid cell line:SK-PN-DW	10719-109I8	147.04	90.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	76.39	23.42	0.53
caudate nucleus - adult, donor10196	10177-103C6	122.04	35.69	2.30
caudate nucleus, adult, donor10252	10164-103B2	56.89	14.72	1.84
caudate nucleus, adult, donor10258	10379-105H1	93.22	28.27	1.53
caudate nucleus, newborn, donor10223	10354-105E3	95.22	19.78	3.30
cerebellum - adult, donor10196	10173-103C2	171.88	75.75	0.00
cerebellum, adult, donor10252	10166-103B4	62.13	19.64	0.21
cerebellum, adult, pool1	10083-102B2	103.14	21.73	0.00
cerebellum, newborn, donor10223	10357-105E6	83.86	19.10	2.49
cerebral meninges, adult	10188-103D8	59.76	20.17	1.76
cerebrospinal fluid, donor2	10294-104G6	38.01	13.89	2.19
cervical cancer cell line:D98-AH2	10552-107I3	64.27	26.89	0.00
cervical cancer cell line:ME-180	10553-107I4	59.33	21.05	4.14
cervix, adult, pool1	10013-101C4	42.94	9.66	2.83
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	136.69	30.79	1.81
chondrosarcoma cell line:SW 1353	10700-109G7	15.68	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	70.96	37.03	0.50
choriocarcinoma cell line:SCH	10785-110H2	41.65	21.93	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	41.27	38.42	0.00
chorionic membrane cells, donor1	12238-129G6	22.51	6.55	1.14
chorionic membrane cells, donor2	12239-129G7	26.05	13.12	0.00
chorionic membrane cells, donor3	12240-129G8	38.46	9.89	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	38.37	27.26	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	140.81	130.05	1.15
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	86.38	44.98	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	88.85	62.92	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	93.12	67.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	79.61	70.86	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	109.54	45.64	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	71.67	47.17	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	88.69	31.77	0.00
clear cell carcinoma cell line:TEN	10636-108I6	55.87	23.60	2.43
colon carcinoma cell line:CACO-2	10513-107D9	55.83	35.33	2.20
colon carcinoma cell line:COLO-320	10420-106C6	118.59	70.32	0.76
colon, adult, donor1	10082-102B1	59.50	39.27	1.19
colon, adult, pool1	10014-101C5	30.32	7.29	1.76
colon, fetal, donor1	10070-101I7	56.85	18.54	0.00
common myeloid progenitor CMP, donor1	12130-128D6	18.33	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	75.11	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	50.57	19.97	5.95
cord blood derived cell line:COBL-a 24h infection	10453-106G3	62.79	32.45	4.08
cord blood derived cell line:COBL-a untreated	10449-106F8	64.44	30.74	5.36
corpus callosum, adult, pool1	10042-101F6	79.49	15.92	1.55
cruciate ligament, donor2	10295-104G7	35.66	15.40	1.62
diaphragm, fetal, donor1	10069-101I6	89.08	40.93	0.00
diencephalon, adult	10193-103E4	69.36	22.08	0.72
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	96.21	94.14	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	49.49	15.64	0.77
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	60.66	57.29	1.20
ductus deferens, adult	10196-103E7	37.87	8.47	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	67.69	23.04	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	62.53	22.07	0.74
dura mater, adult, donor1	10041-101F5	49.14	8.92	1.16
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	26.20	17.32	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	67.35	34.10	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	27.13	1.85	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	41.47	13.92	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	28.10	8.03	0.31
embryonic pancreas cell line:2C6	10603-108E9	26.27	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	65.36	28.16	1.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	81.37	22.29	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	39.08	16.89	1.13
epidermoid carcinoma cell line:A431	10426-106D3	39.13	15.12	0.67
epidermoid carcinoma cell line:Ca Ski	10431-106D8	78.64	33.22	0.88
epididymis, adult	10197-103E8	52.96	9.84	2.72
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	73.27	16.50	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	54.66	22.41	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	81.78	59.89	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	68.30	48.23	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	91.98	63.52	0.00
esophagus, adult, pool1	10015-101C6	30.58	11.68	1.59
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	61.74	12.15	0.38
eye - muscle inferior rectus, donor1	10272-104E2	55.54	2.41	2.41
eye - muscle lateral, donor2	10298-104H1	29.46	8.42	0.00
eye - muscle medial, donor2	10299-104H2	17.86	4.46	0.00
eye - muscle superior, donor2	10297-104G9	48.15	12.61	0.00
eye - vitreous humor, donor1	10268-104D7	34.98	23.32	2.91
eye, fetal, donor1	10054-101G9	73.98	19.07	1.27
fibrosarcoma cell line:HT-1080	10758-110E2	104.89	65.78	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	102.80	44.63	0.95
frontal lobe, adult, pool1	10040-101F4	87.44	24.02	0.56
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	107.19	25.22	5.40
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	40.51	8.96	0.27
gall bladder, adult	10198-103E9	32.35	9.66	0.72
gamma delta positive T cells, donor1	11937-126A2	34.90	35.43	0.54
gamma delta positive T cells, donor2	11938-126A3	29.51	35.11	2.24
gastric adenocarcinoma cell line:MKN1	10614-108G2	96.31	41.82	4.01
gastric adenocarcinoma cell line:MKN45	10612-108F9	49.90	28.82	1.16
gastric cancer cell line:AZ521	10549-107H9	80.50	39.68	0.00
gastric cancer cell line:GSS	10560-108A2	206.84	138.20	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	45.92	21.02	8.45
giant cell carcinoma cell line:LU65	10487-107B1	119.67	47.50	1.26
giant cell carcinoma cell line:Lu99B	10433-106E1	49.55	22.53	1.26
glassy cell carcinoma cell line:HOKUG	10688-109F4	41.65	16.96	3.74
glioblastoma cell line:A172, tech_rep1	10444-106F3	60.27	12.88	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	62.21	15.59	0.28
glioblastoma cell line:T98G	10485-107A8	80.13	27.15	1.43
glioma cell line:GI-1	10413-106B8	41.30	14.94	0.00
globus pallidus - adult, donor10196	10175-103C4	143.60	32.80	0.73
globus pallidus, adult, donor10252	10161-103A8	79.33	19.28	0.73
globus pallidus, adult, donor10258	10367-105F7	97.21	31.49	0.00
globus pallidus, newborn, donor10223	10364-105F4	94.33	20.78	2.13
granulocyte macrophage progenitor, donor1	12131-128D7	31.81	17.13	4.89
granulocyte macrophage progenitor, donor2	12135-128E2	65.57	32.79	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	67.95	73.17	0.00
granulosa cell tumor cell line:KGN	10624-108H3	40.00	11.84	0.00
hIPS +CCl2, biol_rep1	14383-156B9	74.84	71.62	0.00
hIPS +CCl2, biol_rep2	14384-156C1	78.65	67.67	0.00
hIPS +CCl2, biol_rep3	14385-156C2	82.44	98.55	0.00
hIPS, biol_rep1	14380-156B6	44.56	139.42	1.44
hIPS, biol_rep2	14381-156B7	96.02	89.16	0.00
hIPS, biol_rep3	14382-156B8	97.11	32.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	66.09	53.45	0.57
heart - mitral valve, adult	10205-103F7	43.65	9.57	0.00
heart - pulmonic valve, adult	10206-103F8	33.99	9.41	0.00
heart - tricuspid valve, adult	10207-103F9	76.60	10.82	5.00
heart, adult, diseased post-infarction, donor1	10050-101G5	62.03	18.98	0.00
heart, adult, diseased, donor1	10051-101G6	82.61	26.40	0.00
heart, adult, pool1	10016-101C7	50.37	11.96	0.69
heart, fetal, pool1	10046-101G1	52.47	19.00	0.72
hepatic mesenchymal tumor cell line:LI90	10778-110G4	41.65	18.82	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	21.41	17.84	4.76
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	63.98	57.79	2.98
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	55.59	54.86	2.43
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	58.81	56.59	2.73
hepatoma cell line:Li-7	10484-107A7	61.39	26.14	10.12
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	73.37	79.29	0.40
hippocampus - adult, donor10196	10169-103B7	115.45	46.37	0.95
hippocampus, adult, donor10252	10153-102I9	65.11	22.04	1.02
hippocampus, adult, donor10258	10374-105G5	92.62	37.35	0.00
hippocampus, newborn, donor10223	10363-105F3	92.70	25.73	2.47
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	94.60	95.82	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	78.15	51.84	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	88.10	58.14	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	90.22	87.96	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	87.28	57.32	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	97.18	64.91	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	98.68	49.05	1.17
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	86.39	44.16	0.65
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	106.77	52.13	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	81.46	29.60	0.71
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	89.36	41.79	0.80
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	93.59	34.34	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	70.42	54.61	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	69.76	66.82	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	64.58	44.51	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	123.14	68.35	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	120.36	87.65	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	108.95	90.46	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	67.44	33.91	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	95.04	56.84	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	93.66	44.48	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	73.49	30.05	0.65
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	73.45	30.48	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	84.30	47.23	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	72.60	46.93	0.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	89.01	57.63	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	92.28	68.19	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	69.01	55.28	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	80.14	51.95	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	73.84	46.30	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	66.71	36.20	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	86.34	38.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	68.49	33.86	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	72.35	23.01	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	90.11	35.59	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	94.43	41.00	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	71.00	57.24	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	67.74	59.72	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	86.83	63.90	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	74.27	51.65	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	123.62	146.40	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	85.05	54.94	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	69.51	43.78	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	86.85	35.83	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	78.29	31.67	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	68.02	20.29	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	97.91	36.84	0.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	91.06	33.14	0.27
immature langerhans cells, donor1	11904-125F5	40.68	23.49	0.97
immature langerhans cells, donor2	11905-125F6	43.57	19.80	0.00
insula, adult, pool1	10039-101F3	89.33	23.94	1.32
keratoacanthoma cell line:HKA-1	10791-110H8	59.50	40.97	2.28
kidney, adult, pool1	10017-101C8	44.16	14.42	3.50
kidney, fetal, pool1	10045-101F9	43.50	11.32	2.41
large cell lung carcinoma cell line:IA-LM	10509-107D5	100.55	25.28	0.71
large cell lung carcinoma cell line:NCI-H460	10839-111E2	59.72	42.16	0.55
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	46.61	24.41	0.18
left atrium, adult, donor1	10079-102A7	98.07	33.24	0.54
left ventricle, adult, donor1	10078-102A6	90.01	23.77	1.01
leiomyoblastoma cell line:G-402	10721-110A1	41.59	15.87	0.00
leiomyoma cell line:10964C	10569-108B2	18.32	8.98	0.72
leiomyoma cell line:15242A	10570-108B3	23.91	5.98	0.00
leiomyoma cell line:15425	10571-108B4	34.97	7.04	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	69.84	6.35	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	59.60	24.05	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	120.07	111.68	0.59
liposarcoma cell line:KMLS-1	10782-110G8	41.40	14.68	0.31
liposarcoma cell line:SW 872	10726-110A6	120.50	49.22	1.95
liver, adult, pool1	10018-101C9	28.04	6.97	4.86
liver, fetal, pool1	10086-102B5	42.33	16.93	0.00
locus coeruleus - adult, donor10196	10182-103D2	65.33	19.39	0.44
locus coeruleus, adult, donor10252	10165-103B3	63.67	19.93	0.55
locus coeruleus, adult, donor10258	10375-105G6	111.73	34.70	0.28
locus coeruleus, newborn, donor10223	10362-105F2	66.04	18.93	5.47
lung adenocarcinoma cell line:A549	10499-107C4	43.46	18.96	0.55
lung adenocarcinoma cell line:PC-14	10408-106B3	35.85	19.30	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	52.59	18.19	1.71
lung, adult, pool1	10019-101D1	40.87	13.23	3.66
lung, fetal, donor1	10068-101I5	67.36	11.13	7.71
lung, right lower lobe, adult, donor1	10075-102A3	87.06	30.70	3.21
lymph node, adult, donor1	10077-102A5	103.19	46.39	0.95
lymphangiectasia cell line:DS-1	10727-110A7	60.05	76.93	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	100.82	49.50	1.66
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	39.93	5.10	0.00
mature adipocyte, donor1	12231-129F8	40.40	10.21	4.44
mature adipocyte, donor2	12232-129F9	40.47	9.13	2.08
mature adipocyte, donor3	12233-129G1	38.40	11.14	5.22
mature adipocyte, donor4	12234-129G2	44.22	12.11	5.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	81.01	19.30	2.86
medial frontal gyrus - adult, donor10196	10170-103B8	103.78	47.38	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	63.63	17.66	0.92
medial frontal gyrus, adult, donor10258	10368-105F8	105.79	26.05	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	62.69	25.59	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	94.67	26.33	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	67.28	17.83	0.64
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	77.05	55.86	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	100.48	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	88.30	27.28	1.79
medulla oblongata - adult, donor10196	10174-103C3	99.94	44.13	7.79
medulla oblongata, adult, donor10252	10155-103A2	60.99	21.36	3.25
medulla oblongata, adult, pool1	10038-101F2	70.61	13.71	1.88
medulla oblongata, newborn, donor10223	10361-105F1	89.23	19.79	7.29
medulloblastoma cell line:D283 Med	10838-111E1	78.16	60.67	0.22
medulloblastoma cell line:ONS-76	10759-110E3	72.51	38.39	0.37
melanoma cell line:COLO 679	10514-107E1	57.50	23.14	1.29
melanoma cell line:G-361	10465-106H6	75.74	24.70	0.00
meningioma cell line:HKBMM	10691-109F7	51.38	20.08	0.90
merkel cell carcinoma cell line:MKL-1	10843-111E6	73.14	34.37	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	70.77	39.66	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	35.29	16.88	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	20.36	10.91	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	29.82	19.88	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	25.71	13.91	0.84
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	29.08	13.29	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	38.87	10.41	2.08
mesenchymal precursor cell - cardiac, donor1	11752-123G6	26.09	13.56	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	28.87	13.57	0.69
mesenchymal precursor cell - cardiac, donor3	11754-123G8	29.84	13.93	0.40
mesenchymal precursor cell - cardiac, donor4	11755-123G9	37.00	14.58	0.54
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	31.30	15.22	0.43
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	32.28	14.49	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	29.33	15.50	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	37.70	14.66	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	26.34	12.25	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	25.88	7.19	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	26.38	10.14	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	22.57	7.30	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	36.50	15.94	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	27.35	12.25	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	28.18	12.43	0.88
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	26.51	13.99	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	27.47	8.87	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	69.47	21.05	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	34.71	12.79	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	25.07	10.74	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	28.79	10.47	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	29.58	11.09	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	22.36	8.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	29.11	9.48	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	29.08	11.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	22.24	9.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	31.44	12.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	25.43	11.16	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	25.24	9.61	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	34.47	8.80	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	30.54	10.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	25.79	9.83	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	28.78	8.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	32.81	16.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	41.32	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	23.71	12.02	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	23.28	10.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	47.44	21.86	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	35.16	10.63	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	29.15	16.71	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	33.58	8.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	35.76	13.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	28.60	19.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	30.24	10.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	36.55	8.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	54.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	41.17	17.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	30.70	12.76	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	30.09	12.90	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	39.92	7.98	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	44.77	10.33	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	15.89	17.52	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	24.63	11.92	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	20.04	18.28	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	22.75	18.08	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	37.43	14.70	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	46.12	24.84	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	48.79	12.84	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	42.68	15.83	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	58.39	27.71	7.42
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	58.32	32.52	5.61
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	62.33	30.53	8.90
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	71.73	27.81	9.67
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	93.77	30.53	6.54
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	60.82	22.81	12.67
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	76.47	16.99	4.25
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	112.97	36.15	9.04
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	70.01	46.13	6.59
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	35.32	11.31	1.19
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	37.32	16.22	1.95
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	37.69	16.30	3.06
mesodermal tumor cell line:HIRS-BM	10696-109G3	13.15	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	64.26	13.23	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	56.53	15.06	1.16
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	72.65	51.28	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	65.25	26.92	0.41
mesothelioma cell line:Mero-25	10850-111F4	69.22	32.45	1.59
mesothelioma cell line:Mero-41	10851-111F5	96.57	25.91	1.47
mesothelioma cell line:Mero-48a	10852-111F6	82.15	42.96	0.22
mesothelioma cell line:Mero-82	10853-111F7	53.09	31.80	0.53
mesothelioma cell line:Mero-83	10854-111F8	80.51	43.92	0.34
mesothelioma cell line:Mero-84	10855-111F9	61.17	26.79	1.26
mesothelioma cell line:Mero-95	10856-111G1	62.11	24.02	2.48
mesothelioma cell line:NCI-H2052	10847-111F1	82.16	37.77	0.83
mesothelioma cell line:NCI-H226	10846-111E9	66.79	33.66	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	85.75	29.72	0.17
mesothelioma cell line:NCI-H28	10845-111E8	111.71	51.15	0.00
mesothelioma cell line:No36	10857-111G2	115.80	53.82	0.00
mesothelioma cell line:ONE58	10858-111G3	83.18	37.93	2.98
migratory langerhans cells, donor1	11901-125F2	41.26	21.11	0.58
migratory langerhans cells, donor2	11902-125F3	46.65	16.49	0.12
migratory langerhans cells, donor3	11903-125F4	47.74	34.10	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	84.56	28.08	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	79.69	33.70	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	69.80	39.16	0.92
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	46.05	34.63	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	117.16	66.34	0.18
myeloma cell line:PCM6	10474-106I6	47.04	20.16	1.19
myxofibrosarcoma cell line:MFH-ino	10600-108E6	32.47	9.13	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	57.27	25.30	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	36.10	19.05	1.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	34.71	21.03	0.66
nasal epithelial cells, donor2	12227-129F4	40.85	14.35	1.66
neuroblastoma cell line:CHP-134	10508-107D4	65.57	28.53	0.00
neuroblastoma cell line:NB-1	10539-107G8	64.36	20.02	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	74.87	35.64	1.48
neuroblastoma cell line:NH-12	10555-107I6	73.80	67.27	0.93
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	60.26	31.79	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	76.34	29.62	0.95
neuroectodermal tumor cell line:TASK1	10774-110F9	129.61	84.53	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	68.66	24.79	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	45.51	18.63	0.27
neutrophil PMN, donor1	12133-128D9	0.00	14.87	0.00
neutrophil PMN, donor2	12137-128E4	13.28	13.28	0.00
neutrophil PMN, donor3	12141-128E8	18.94	28.41	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	85.91	59.87	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	40.83	12.81	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	39.11	14.11	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	36.52	8.93	0.26
nucleus accumbens, adult, pool1	10037-101F1	80.24	18.84	0.66
occipital cortex - adult, donor10196	10172-103C1	168.95	39.15	0.00
occipital cortex, adult, donor10252	10163-103B1	59.58	17.71	0.00
occipital cortex, newborn, donor10223	10355-105E4	82.25	21.84	1.09
occipital lobe, adult, donor1	10076-102A4	165.57	44.08	0.26
occipital lobe, fetal, donor1	10073-102A1	252.31	79.81	0.43
occipital pole, adult, pool1	10036-101E9	61.26	13.01	0.24
olfactory region, adult	10195-103E6	72.03	22.74	0.57
optic nerve, donor1	10277-104E7	102.05	18.01	4.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	96.59	36.22	0.68
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	31.05	14.70	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	73.83	26.08	1.02
oral squamous cell carcinoma cell line:SAS	10544-107H4	46.20	36.85	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	47.03	15.87	0.88
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	23.36	22.42	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	35.20	8.48	0.85
ovary, adult, pool1	10020-101D2	38.70	10.74	5.15
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	101.74	61.05	0.37
pancreas, adult, donor1	10049-101G4	63.02	19.75	2.82
pancreatic carcinoma cell line:NOR-P1	10698-109G5	183.93	86.66	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	106.98	31.69	1.02
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	61.43	21.69	1.99
paracentral gyrus, adult, pool1	10035-101E8	84.02	24.25	0.82
parietal cortex, adult, donor10258	10373-105G4	73.40	20.55	0.00
parietal lobe - adult, donor10196	10171-103B9	101.57	31.04	0.00
parietal lobe, adult, donor10252	10157-103A4	66.70	15.39	0.00
parietal lobe, adult, pool1	10034-101E7	75.69	20.09	0.18
parietal lobe, fetal, donor1	10072-101I9	271.55	96.98	0.00
parietal lobe, newborn, donor10223	10356-105E5	83.00	18.69	2.24
parotid gland, adult	10199-103F1	57.35	20.35	0.00
penis, adult	10200-103F2	42.97	14.50	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	36.44	12.09	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	115.10	34.68	2.91
pineal gland - adult, donor10196	10179-103C8	110.30	29.67	1.29
pineal gland, adult, donor10252	10160-103A7	128.51	27.24	0.59
pineal gland, adult, donor10258	10377-105G8	74.62	22.57	0.63
pituitary gland - adult, donor10196	10180-103C9	81.96	41.48	9.11
pituitary gland, adult, donor10252	10162-103A9	97.46	38.57	10.42
pituitary gland, adult, donor10258	10378-105G9	78.31	36.60	3.40
placenta, adult, pool1	10021-101D3	43.65	10.00	6.67
plasma cell leukemia cell line:ARH-77	10840-111E3	59.33	52.97	0.26
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	66.77	15.56	0.00
pons, adult, pool1	10033-101E6	64.21	17.56	0.95
postcentral gyrus, adult, pool1	10032-101E5	75.58	19.00	0.52
promyelocytes/myelocytes PMC, donor1	12132-128D8	23.01	14.64	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	99.14	99.14	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	70.41	35.21	0.00
prostate cancer cell line:DU145	10490-107B4	64.38	25.64	0.15
prostate cancer cell line:PC-3	10439-106E7	131.23	44.10	0.54
prostate, adult, pool1	10022-101D4	34.10	7.16	2.00
putamen, adult, donor10196	10176-103C5	75.54	19.36	0.94
putamen, adult, donor10252	10152-102I8	54.90	5.88	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	44.81	61.20	3.28
putamen, adult, donor10258, tech_rep2	10372-105G3	60.16	12.08	0.72
putamen, newborn, donor10223	10365-105F5	50.98	20.99	1.50
rectal cancer cell line:TT1TKB	10469-106I1	45.68	23.27	0.58
rectum, fetal, donor1	10067-101I4	107.11	25.04	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	58.30	11.24	0.85
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	23.20	14.08	0.83
retina, adult, pool1	10030-101E3	72.36	14.91	1.59
retinoblastoma cell line:Y79	10475-106I7	150.17	96.91	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	74.63	33.44	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	77.33	34.59	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	18.19	7.58	0.00
salivary acinar cells, donor1	11771-123I7	43.54	22.82	1.13
salivary acinar cells, donor2	11772-123I8	45.99	18.45	0.28
salivary acinar cells, donor3	11773-123I9	17.21	7.94	0.66
salivary gland, adult, pool1	10093-102C3	54.34	18.30	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	64.50	22.43	0.25
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	67.71	24.92	0.71
seminal vesicle, adult	10201-103F3	53.44	6.88	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	58.79	21.62	2.19
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	43.78	21.14	2.01
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	54.19	21.07	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	58.83	27.67	9.67
signet ring carcinoma cell line:Kato III	10436-106E4	44.21	17.91	4.31
signet ring carcinoma cell line:NUGC-4	10483-107A6	78.71	43.48	2.58
skeletal muscle - soleus muscle, donor1	10282-104F3	48.94	4.26	0.00
skeletal muscle, adult, pool1	10023-101D5	42.22	12.47	0.60
skeletal muscle, fetal, donor1	10066-101I3	104.52	103.52	0.00
skin, adult, donor1	10074-102A2	108.56	20.36	0.00
skin, fetal, donor1	10065-101I2	101.00	27.77	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	36.69	10.34	4.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	77.23	23.01	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	60.91	20.05	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	40.55	19.45	1.98
small cell lung carcinoma cell line:NCI-H82	10842-111E5	179.99	138.01	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	62.32	29.85	13.95
small intestine, adult, pool1	10024-101D6	29.26	11.82	0.96
small intestine, fetal, donor1	10064-101I1	53.32	27.52	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	45.65	16.93	5.64
smooth muscle, adult, pool1	10048-101G3	43.94	19.90	1.03
somatostatinoma cell line:QGP-1	10781-110G7	34.31	15.81	2.41
spinal cord - adult, donor10196	10181-103D1	107.36	33.72	1.15
spinal cord, adult, donor10252	10159-103A6	82.01	25.63	1.18
spinal cord, adult, donor10258	10369-105F9	105.84	44.27	0.69
spinal cord, fetal, donor1	10056-101H2	129.89	29.27	0.61
spinal cord, newborn, donor10223	10359-105E8	66.13	28.47	4.59
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	37.64	15.98	0.15
spleen, adult, pool1	10025-101D7	42.29	13.99	1.10
spleen, fetal, pool1	10044-101F8	32.18	11.20	0.87
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	48.96	28.16	0.41
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	26.01	9.30	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	45.43	11.18	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	86.00	40.27	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	155.44	50.31	4.05
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	202.06	143.18	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	134.54	81.23	0.00
stomach, fetal, donor1	10062-101H8	40.58	12.82	3.20
submaxillary gland, adult	10202-103F4	45.57	18.80	0.00
substantia nigra - adult, donor10196	10178-103C7	108.55	54.27	0.00
substantia nigra, adult, donor10252	10158-103A5	62.10	19.73	0.42
substantia nigra, adult, donor10258	10371-105G2	107.07	38.79	0.00
substantia nigra, newborn, donor10223	10358-105E7	107.40	25.44	5.65
synovial sarcoma cell line:HS-SY-II	10441-106E9	66.26	31.87	0.00
temporal lobe, adult, pool1	10031-101E4	62.22	14.07	0.42
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	205.13	61.97	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	116.92	47.03	0.00
tenocyte, donor1	11763-123H8	25.83	11.17	0.00
tenocyte, donor2	11765-123I1	24.42	13.73	1.14
tenocyte, donor3	11768-123I4	40.40	12.97	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	227.24	151.94	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	162.16	118.39	0.15
teratocarcinoma cell line:PA-1	10807-111A6	121.81	99.81	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	116.41	64.24	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	166.77	81.31	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	35.55	26.94	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	64.81	43.97	0.00
testis, adult, pool1	10026-101D8	45.20	15.25	3.01
testis, adult, pool2	10096-102C6	82.10	32.93	1.80
thalamus - adult, donor10196	10168-103B6	117.02	40.85	1.10
thalamus, adult, donor10252	10154-103A1	57.98	20.94	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	56.97	83.14	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	82.84	27.17	0.82
thalamus, newborn, donor10223	10366-105F6	58.68	13.81	3.45
throat, adult	10209-103G2	42.94	13.73	2.25
throat, fetal, donor1	10061-101H7	77.70	14.63	4.57
thymic carcinoma cell line:Ty-82	10803-111A2	91.22	58.03	0.60
thymus, adult, pool1	10027-101D9	56.17	23.86	0.10
thymus, fetal, pool1	10043-101F7	45.72	17.14	0.42
thyroid carcinoma cell line:KHM-5M	10776-110G2	142.93	68.47	0.53
thyroid carcinoma cell line:TCO-1	10783-110G9	137.32	69.85	0.84
thyroid, adult, pool1	10028-101E1	51.14	14.46	2.43
thyroid, fetal, donor1	10060-101H6	99.93	20.30	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	33.88	18.48	3.08
tongue, adult	10203-103F5	43.72	18.37	0.23
tongue, fetal, donor1	10059-101H5	111.53	48.08	0.39
tonsil, adult, pool1	10047-101G2	47.28	15.43	0.80
trachea, adult, pool1	10029-101E2	28.71	8.67	8.02
trachea, fetal, donor1	10058-101H4	65.78	20.00	2.31
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	82.90	23.38	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	61.50	22.90	1.22
transitional-cell carcinoma cell line:JMSU1	10492-107B6	113.13	52.18	0.31
tridermal teratoma cell line:HGRT	10694-109G1	11.42	5.71	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	77.71	46.47	0.34
umbilical cord, fetal, donor1	10057-101H3	47.99	27.12	0.00
uterus, adult, pool1	10100-102D1	58.35	9.90	2.90
uterus, fetal, donor1	10055-101H1	70.65	20.99	1.02
vagina, adult	10204-103F6	35.54	8.40	1.94
vein, adult	10191-103E2	53.70	16.44	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	36.32	42.19	0.00